|
1
|
Kispert A, Koschorz B and Herrmann BG: The
T protein encoded by Brachyury is a tissue-specific transcription
factor. EMBO J. 14:4763–4772. 1995.PubMed/NCBI
|
|
2
|
Haro A, Yano T, Kohno M, Yoshida T, Koga
T, Okamoto T, Takenoyama M and Maehara Y: Expression of Brachyury
gene is a significant prognostic factor for primary lung carcinoma.
Ann Surg Oncol. 20(Suppl 3): S509–S516. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Imajyo I, Sugiura T, Kobayashi Y, Shimoda
M, Ishii K, Akimoto N, Yoshihama N, Kobayashi I and Mori Y: T-box
transcription factor Brachyury expression is correlated with
epithelial-mesenchymal transition and lymph node metastasis in oral
squamous cell carcinoma. Int J Oncol. 41:1985–1995. 2012.PubMed/NCBI
|
|
4
|
Kilic N, Feldhaus S, Kilic E, Tennstedt P,
Wicklein D, Wasielewski R, Viebahn C, Kreipe H and Schumacher U:
Brachyury expression predicts poor prognosis at early stages of
colorectal cancer. Eur J Cancer. 47:1080–1085. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roselli M, Fernando RI, Guadagni F, Spila
A, Alessandroni J, Palmirotta R, Costarelli L, Litzinger M,
Hamilton D, Huang B, et al: Brachyury, a driver of the
epithelial-mesenchymal transition, is overexpressed in human lung
tumors: An opportunity for novel interventions against lung cancer.
Clin Cancer Res. 18:3868–3879. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fernando RI, Litzinger M, Trono P,
Hamilton DH, Schlom J and Palena C: The T-box transcription factor
Brachyury promotes epithelial-mesenchymal transition in human tumor
cells. J Clin Invest. 120:533–544. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu K, Liu B and Liu Y: Impact of Brachyury
on epithelial-mesenchymal transitions and chemosensitivity in
non-small cell lung cancer. Mol Med Rep. 12:995–1001.
2015.PubMed/NCBI
|
|
8
|
Kleiner DE and Stetler-Stevenson WG:
Matrix metalloproteinases and metastasis. Cancer Chemother
Pharmacol. 43(Suppl): S42–S51. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sternlicht MD and Werb Z: How matrix
metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol.
17:463–516. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang R, Ke ZF, Wang F, Zhang WH, Wang YF,
Li SH and Wang LT: GOLPH3 overexpression is closely correlated with
poor prognosis in human non-small cell lung cancer and mediates its
metastasis through upregulating MMP-2 and MMP-9. Cell Physiol
Biochem. 35:969–982. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ali-Labib R, Louka ML, Galal IH and Tarek
M: Evaluation of matrix metalloproteinase-2 in lung cancer.
Proteomics Clin Appl. 8:251–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Luo J, Ni J, Tang L, Zhang HP,
Zhang L, Xu JF and Zheng D: MMP-7 is upregulated by COX-2 and
promotes proliferation and invasion of lung adenocarcinoma cells.
Eur J Histochem. 58:22622014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liang Y, Guo S and Zhou Q: Prognostic
value of matrix metalloproteinase-7 expression in patients with
non-small cell lung cancer. Tumour Biol. 35:3717–3724. 2014.
View Article : Google Scholar
|
|
14
|
Ruiz-Morales JM, Dorantes-Heredia R,
Arrieta O, Chavez-Tapia NC and Motola-Kuba D: Neutrophil
gelatinase-associated lipocalin (NGAL) and matrix
metalloproteinase-9 (MMP-9) prognostic value in lung
adenocarcinoma. Tumour Biol. 36:3601–3610. 2015. View Article : Google Scholar
|
|
15
|
Gill JH, Kirwan IG, Seargent JM, Martin
SW, Tijani S, Anikin VA, Mearns AJ, Bibby MC, Anthoney A and
Loadman PM: MMP-10 is overexpressed, proteolytically active, and a
potential target for therapeutic intervention in human lung
carcinomas. Neoplasia. 6:777–785. 2004. View Article : Google Scholar
|
|
16
|
Kettunen E, Anttila S, Seppänen JK,
Karjalainen A, Edgren H, Lindström I, Salovaara R, Nissén AM, Salo
J, Mattson K, et al: Differentially expressed genes in nonsmall
cell lung cancer: Expression profiling of cancer-related genes in
squamous cell lung cancer. Cancer Genet Cytogenet. 149:98–106.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cho NH, Hong KP, Hong SH, Kang S, Chung KY
and Cho SH: MMP expression profiling in recurred stage IB lung
cancer. Oncogene. 23:845–851. 2004. View Article : Google Scholar
|
|
18
|
Wang YZ, Wu KP, Wu AB, Yang ZC, Li JM, Mo
YL, Xu M, Wu B and Yang ZX: MMP-14 overexpression correlates with
poor prognosis in non-small cell lung cancer. Tumour Biol.
35:9815–9821. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou H, Wu A, Fu W, Lv Z and Zhang Z:
Significance of semaphorin-3A and MMP-14 protein expression in
non-small cell lung cancer. Oncol Lett. 7:1395–1400.
2014.PubMed/NCBI
|
|
20
|
Yu G, Herazo-Maya JD, Nukui T, Romkes M,
Parwani A, Juan-Guardela BM, Robertson J, Gauldie J, Siegfried JM,
Kaminski N, et al: Matrix metalloproteinase-19 promotes metastatic
behavior in vitro and is associated with increased mortality in
non-small cell lung cancer. Am J Respir Crit Care Med. 190:780–790.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Zhao H, Wang Y, Lin Y, Tan Y,
Fang X and Zheng L: Non-small cell lung cancer invasion and
metastasis promoted by MMP-26. Mol Med Rep. 4:1201–1209.
2011.PubMed/NCBI
|
|
22
|
Li J, Zhu L, Qu X, Li J, Lin R, Liao L,
Wang J, Wang S, Xu Q and Zhao RC: Stepwise differentiation of human
adipose-derived mesenchymal stem cells toward definitive endoderm
and pancreatic progenitor cells by mimicking pancreatic development
in vivo. Stem Cells Dev. 22:1576–1587. 2013. View Article : Google Scholar
|
|
23
|
Wang HZ, He YX, Yang CJ, Zhou W and Zou
CG: Hepcidin is regulated during blood-stage malaria and plays a
protective role in malaria infection. J Immunol. 187:6410–6416.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sarkar S, Nuttall RK, Liu S, Edwards DR
and Yong VW: Tenascin-C stimulates glioma cell invasion through
matrix metalloproteinase-12. Cancer Res. 66:11771–11780. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Edwards YH, Putt W, Lekoape KM, Stott D,
Fox M, Hopkinson DA and Sowden J: The human homolog T of the mouse
T(Brachyury) gene; Gene structure, cDNA sequence, and assignment to
chromosome 6q27. Genome Res. 6:226–233. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ali A, Wang Z, Fu J, Ji L, Liu J, Li L,
Wang H, Chen J, Caulin C, Myers JN, Zhang P, Xiao J, Zhang B and Li
X: Differential regulation of the REGγ-proteasome pathway by
p53/TGF-β signalling and mutant p53 in cancer cells. Nat Commun.
4:26672013. View Article : Google Scholar
|
|
27
|
Krukovskaia LL, Polev DE, Nosova Iu K,
Baranova AV, Koliubaeva SN and Kozlov AP: Investigation of
transcription factor Brachyury (T) expression in human normal and
tumor tissues. Vopr Onkol. 54:739–743. 2008.In Russian.
|
|
28
|
Palena C, Fernando RI, Hamilton DH, Huang
B and Schlom J: Brachyury, a driver of tumor invasiveness and
resistance to multiple therapies, is a novel immunotherapy target.
J Immunother Cancer. 1(Suppl 1): P2302013. View Article : Google Scholar
|
|
29
|
Kobayashi Y, Sugiura T, Imajyo I, Shimoda
M, Ishii K, Akimoto N, Yoshihama N and Mori Y: Knockdown of the
T-box transcription factor Brachyury increases sensitivity of
adenoid cystic carcinoma cells to chemotherapy and radiation in
vitro: Implications for a new therapeutic principle. Int J Oncol.
44:1107–1117. 2014.PubMed/NCBI
|
|
30
|
Pinto F, Pértega-Gomes N, Pereira MS,
Vizcaíno JR, Monteiro P, Henrique RM, Baltazar F, Andrade RP and
Reis RM: T-box transcription factor brachyury is associated with
prostate cancer progression and aggressiveness. Clin Cancer Res.
20:4949–4961. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hofmann HS, Hansen G, Richter G, Taege C,
Simm A, Silber RE and Burdach S: Matrix metalloproteinase-12
expression correlates with local recurrence and metastatic disease
in non-small cell lung cancer patients. Clin Cancer Res.
11:1086–1092. 2005.PubMed/NCBI
|
|
32
|
Weigelt B, Glas AM, Wessels LF, Witteveen
AT, Peterse JL and van't Veer LJ: Gene expression profiles of
primary breast tumors maintained in distant metastases. Proc Natl
Acad Sci USA. 100:15901–15905. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gomez-Roca C, Raynaud CM, Penault-Llorca
F, Mercier O, Commo F, Morat L, Sabatier L, Dartevelle P, Taranchon
E, Besse B, et al: Differential expression of biomarkers in primary
non-small cell lung cancer and metastatic sites. J Thorac Oncol.
4:1212–1220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sarkar D, Shields B, Davies ML, Muller J
and Wakeman JA: Brachyury confers cancer stem cell characteristics
on colorectal cancer cells. Int J Cancer. 130:328–337. 2012.
View Article : Google Scholar
|
|
35
|
Palena C, Roselli M, Litzinger MT, Ferroni
P, Costarelli L, Spila A, Cavaliere F, Huang B, Fernando RI,
Hamilton DH, et al: Overexpression of the EMT driver brachyury in
breast carcinomas: Association with poor prognosis. J Natl Cancer
Inst. 106:piidju054. 2014. View Article : Google Scholar
|
